Covance Wins “Best CRO” Award for Supporting Global Vaccine Development
Covance recognized for providing superior vaccine services to biopharmaceutical industry.
Princeton, NJ-May 5, 2008-Covance (www.covance.com), the world’s largest publicly traded contract research organization, today announced that it has won the “Best Contract Research Organization (CRO)” award at the 2008 World Vaccine Congress, held recently in Washington, DC. As part of the Vaccine Industry Excellence (ViE) awards, the Best CRO award is designed to highlight the importance of contract research services within the vaccine industry. This award recognizes Covance as best-in-class when it comes to providing services that support vaccine development.
“This recognition reaffirms our commitment to providing vaccine services that encompass all phases of development,” said Wendel Barr, chief operating officer for Covance. “We understand that each vaccine is unique, and therefore we offer services and experience-including scientific, technical, and regulatory expertise-across different types of vaccines to help guide our customers through the complexities of vaccine development.”
A panel of international judges selected Covance based on the company’s state-of-the-art facilities, vaccine services, and superior customer relations that together help biopharmaceutical companies speed vaccine development. The ViE Awards were created to honor and generate public recognition of the efforts, accomplishments, and positive contributions of organizations and individuals in the global vaccine industry.
The global vaccine market generated sales of $13.5 billion in 2006 and is expected to reach $24.8 billion by 2013, according to a 2007 report published by Wood Mackenzie, a research and consulting firm.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
